Introduction
Mitral annulus calcification (MAC) is a non-inflammatory chronic degenerative process of the fibrous support structure of the mitral valve, preferentially involving the posterior part of the mitral annulus and often associated with risk factors of athero-thrombosis. 1 It is observed in 10% of the elderly men and about 16% of the elderly women. 2 MAC may also occur in younger patients with advanced renal disease or other metabolic disorders that result in abnormal calcium metabolism. The putative sequelae of MAC include mitral stenosis, mitral regurgitation, infective endocarditis, atrial arrhythmias, heart block, congestive heart failure and stroke. 3 The
Framingham study revealed that stroke was twice more frequent in patients with MAC despite adjustment for conventional risk factors and independent of presence or absence of atrial fibrillation and/or heart failure. 2 A possible link between MAC and cerebral embolism was reported in a study that comprised 16 autopsies, but none of which showed a thrombus on the mitral annulus. 4 A recent study has shown spontaneous fistulization of the caseous calcification and extrusion of the cheesy material mixed with calcium as the mechanism of embolic stroke. 5 The exact mechanism of stroke in MAC is speculative and possibly multi-factorial; however a total of about twenty cases have been reported so far in the literature with vanishing mobile masses on the calcified annulus consistent with thrombi. [6] [7] [8] [9] [10] [11] [12] [13] [14] This report deals with an elderly person with recurrent cerebral embolism, who was detected to have a large mobile mass on the ventricular surface of the mitral annulus consistent with thrombus in one of the several echocardiographic examinations. The mass and neurological symptoms disappeared on anti-coagulation.
Case report
A 73-year-old man with long-standing diabetes mellitus, hypertension and previous coronary bypass surgery i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) s 1 3 1 -s 1 3 4 a b s t r a c t . After comparing echocardiographic images with her last two studies (1 year and six months before admission), we were able to verify the newly developed mobile mass on the MAC. The mass was on the ventricular surface of the posteromedial annulus at the top of a calcified ridge, highly mobile and echo-dense. There was no clinical or echocardiographic evidence of infective endocarditis. Multi-planar reconstruction of the 3D echocardiographic acquisition showed the mass to be of uniform density and not obstructing the mitral orifice (Fig. 3) . Doppler duplex examination of the neck vessels showed small, calcified plaques in both internal carotid arteries. Thus, 2 mg/ day oral warfarin was started and gradually increased to get INR in therapeutic range. Additional laboratory tests including 2 sets of tests for blood cultures, coagulation function (antithrombin-III, fibrin degradation products, protein C, and protein S), tumor markers (carcinoembryonic antigen, CA19-9), and autoimmune antibodies (anti-nuclear antigen, anti-DNA antigen, and anticardiolipin IgG) were negative. After two weeks of anticoagulation, TTE was repeated and the mobile mass was no longer present ( Figs. 1 and 3) . Real-time, three-dimensional trans-thoracic echocardiography was successfully used to visualize the mobile mass on the MAC (Fig. 3, Video 2) . Fig. 1 -Modified 4-chamber view (A) showing an oblong echo-dense mass on MAC (yellow arrow). Real-time 3D echocardiographic image (B) showing the mass (white arrow).
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Discussion
Although several studies have demonstrated an association between MAC and stroke; a causal link has not been established. 1, 2 The causes of stroke in patients with MAC are uncertain, but most speculation has centered on an embolic pathogenesis. Autopsy reports have documented calcific emboli to the brain and other organs in a few patients with MAC. 4, 5 Some authors have also suggested that MAC serves as a nidus for thrombus formation. [6] [7] [8] [9] [10] [11] [12] [13] [14] The present case supports this hypothesis. In our case of recurrent cerebral infarction, one of the echocardiographic studies showed a newly developed mobile mass, which could directly cause cerebral embolism. In our case, the mass was located on the ventricular side of the MAC of the posterior leaflet and disappeared after 3 weeks of anticoagulation therapy. Although the precise mechanisms of the development of the mobile mass on the MAC are unknown, it is possible to postulate that the morphology and the size of the MAC affect the process of the mobile mass formation on the MAC. Liquefaction necrosis, caseous transformation and ulceration of the mitral valve endothelium, with exposure of [ ( F i g . _ 3 ) T D $ F I G ] i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) s 1 3 1 -s 1 3 4
S133
underlying calcium has been demonstrated in autopsy studies 4 and may provide a nidus for thrombus formation. In this autopsy study, two-thirds of the stroke in the presence of MAC were considered embolic. Because one third of the strokes in the subjects with MAC were considered to be non-embolic (atherothrombotic or hemorrhagic), other mechanisms of the relation between MAC and stroke must be considered. Earlier reports linked MAC with advancing age, elevated systolic blood pressure, diabetes mellitus, atrial fibrillation, heart failure and atherosclerosis. ; however, the frequency might be underestimated. It is difficult to detect a small mass beside the massive MAC, especially with ultrasound artifacts and hence, the relationship between a mass on the MAC and systemic embolism is not well recognized. Careful observation of both ventricular and atrial sides of a MAC is needed to evaluate possible embolic sources by using transthoracic echocardiography. 80% of the patients with MAC and superimposed mobile mass are symptomatic with cerebral embolism. [6] [7] [8] [9] [10] [11] [12] [13] [14] A majority of the masses were on the posterior part of the annulus and also on the ventricular surface. In summary, super-imposed thrombus on MAC is underappreciated as a potential cause of stroke. Clinicians need to consider this potential entity in patients with extensive MAC and a thrombo-embolic event as the diagnosis may significantly modify treatment. However, until large studies can confirm, it is difficult to propose routine anti-coagulation in patients with MAC, who develop stroke unless definite thrombi can be demonstrated.
